Filtros de búsqueda

Lista de obras de Julie McElrath

0A07-01. HIV-specific CD8+ T-cells of vaccinees exhibit proliferative and cytotoxic capacities comparable to those of progressors

article

1272. Feasibility and Successful Enrollment in Proof-of-Concept Trials to Assess Safety and Efficacy of a Broadly Neutralizing Monoclonal Antibody, VRC01, to Prevent HIV-1 Acquisitionin in Uninfected Individuals

A Phase II Study of Two HIV Type 1 Envelope Vaccines, Comparing Their Immunogenicity in Populations at Risk for Acquiring HIV Type 1 Infection

article

A Systems Vaccinology Approach Reveals Temporal Transcriptomic Changes of Immune Responses to the Yellow Fever 17D Vaccine.

artículo científico publicado en 2017

A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteers

artículo científico publicado en 1999

A framework for assessing immunological correlates of protection in vaccine trials

artículo científico publicado en 2007

A novel HIV vaccine adjuvanted by IC31 induces robust and persistent humoral and cellular immunity

artículo científico publicado en 2012

A phase 1b randomized study of the safety and immunological responses to vaccination with H4:IC31, H56:IC31, and BCG revaccination in Mycobacterium tuberculosis-uninfected adolescents in Cape Town, South Africa

scientific article published on 18 March 2020

A phase I trial of preventive HIV vaccination with heterologous poxviral-vectors containing matching HIV-1 inserts in healthy HIV-uninfected subjects

artículo científico publicado en 2011

A phase IIA randomized clinical trial of a multiclade HIV-1 DNA prime followed by a multiclade rAd5 HIV-1 vaccine boost in healthy adults (HVTN204)

artículo científico publicado en 2011

A randomized controlled safety/efficacy trial of therapeutic vaccination in HIV-infected individuals who initiated antiretroviral therapy early in infection.

artículo científico publicado en 2017

A side-by-side comparison of T cell reactivity to fifty-nine Mycobacterium tuberculosis antigens in diverse populations from five continents

artículo científico publicado en 2015

A study of vaccine-induced immune pressure on breakthrough infections in the Phambili phase 2b HIV-1 vaccine efficacy trial

artículo científico publicado en 2016

A trimeric, V2-deleted HIV-1 envelope glycoprotein vaccine elicits potent neutralizing antibodies but limited breadth of neutralization in human volunteers

artículo científico publicado en 2011

Abacavir hypersensitivity reaction in primary HIV infection

artículo científico publicado en 2006

Absence of Immunodominant Anti-Gag p17 (SL9) Responses among Gag CTL-Positive, HIV-Uninfected Vaccine Recipients Expressing the HLA-A*0201 Allele

article

Activated PD-1+ CD4+ T cells represent a short-lived part of the viral reservoir and predict poor immunologic recovery upon initiation of ART

scientific article published on 01 February 2020

Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.

artículo científico publicado en 2010

Adenovirus Serotype 5 Vaccination Results in Suboptimal CD4 T Helper 1 Responses in Mice

artículo científico publicado en 2016

Adjuvants: tailoring humoral immune responses

artículo científico publicado en 2017

Administration of recombinant interleukin-2 reduces the local parasite load of patients with disseminated cutaneous leishmaniasis

artículo científico publicado en 1990

Advancing AIDSVAX to phase 3. Safety, immunogenicity, and plans for phase 3.

artículo científico publicado en 1998

Alterations in T cell phenotype and human immunodeficiency virus type 1-specific cytotoxicity after potent antiretroviral therapy

artículo científico publicado en 2001

An Antibody Targeting the Fusion Machinery Neutralizes Dual-Tropic Infection and Defines a Site of Vulnerability on Epstein-Barr Virus.

artículo científico publicado en 2018

An excess of rare genetic variation in ABCE1 among Yorubans and African-American individuals with HIV-1.

artículo científico publicado en 2009

Analysis of HLA A*02 association with vaccine efficacy in the RV144 HIV-1 vaccine trial

artículo científico publicado en 2014

Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic Mutation

scientific article published on 08 June 2020

Analysis of genetic polymorphisms in CCR5, CCR2, stromal cell-derived factor-1, RANTES, and dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin in seronegative individuals repeatedly exposed to HIV-1

scientific article published on 02 August 2004

Analysis of intercurrent human immunodeficiency virus type 1 infections in phase I and II trials of candidate AIDS vaccines. AIDS Vaccine Evaluation Group, and the Correlates of HIV Immune Protection Group

artículo científico publicado en 1998

Antagonism of vaccine-induced HIV-1-specific CD4+ T cells by primary HIV-1 infection: potential mechanism of vaccine failure

artículo científico publicado en 1997

Antibody Fc effector functions and IgG3 associate with decreased HIV-1 risk

scientific article published on 01 November 2019

Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials

artículo científico publicado en 2020

Antigenic competition in CD4+ T cell responses in a randomized, multicenter, double-blind clinical HIV vaccine trial

artículo científico publicado en 2019

Antiretroviral Pre-Exposure Prophylaxis Does Not Enhance Immune Responses to HIV in Exposed but Uninfected Persons

artículo científico publicado en 2014

Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention: A Randomized Trial

artículo científico publicado en 2016

Association between peripheral γδ T-cell profile and disease progression in individuals infected with HIV-1 or HIV-2 in West Africa

artículo científico publicado en 2011

Association of T cell proliferative responses and phenotype with virus control in chronic progressive HIV-1 disease

artículo científico publicado en 2004

BCG revaccination boosts adaptive polyfunctional Th1/Th17 and innate effectors in IGRA+ and IGRA- Indian adults

scientific article published on 19 December 2019

Basis and Statistical Design of the Passive HIV-1 Antibody Mediated Prevention (AMP) Test-of-Concept Efficacy Trials

artículo científico publicado en 2017

Benefits of a comprehensive quality program for cryopreserved PBMC covering 28 clinical trials sites utilizing an integrated, analytical web-based portal

artículo científico publicado en 2014

Beta-lactamase inhibition by acetylmethylene penicillanic acid compared to that of clavulanate and sulbactam

artículo científico publicado en 1988

Breakthrough infections during phase 1 and 2 prime-boost HIV-1 vaccine trials with canarypox vectors (ALVAC) and booster dose of recombinant gp120 or gp160

artículo científico publicado en 2004

Broad and Potent Neutralizing Antibodies Recognize the Silent Face of the HIV Envelope

artículo científico publicado en 2019

Broadly Increased Sensitivity to Cytotoxic T Lymphocytes Resulting from Nef Epitope Escape Mutations ⬇️

artículo científico publicado el 15 de octubre de 2003

CD4+ T cell receptor repertoire perturbations in HIV-1 infection: association with plasma viremia and disease progression

artículo científico publicado en 2006

CD8 CTL responses in vaccines: emerging patterns of HLA restriction and epitope recognition

article

COMPASS identifies T-cell subsets correlated with clinical outcomes

artículo científico publicado en 2015

COVID-19 and the Path to Immunity

artículo científico publicado en 2020

CXCL13 is a plasma biomarker of germinal center activity

artículo científico publicado en 2016

CXCR3 enables recruitment and site-specific bystander activation of memory CD8+ T cells

artículo científico publicado en 2019

Cell free HIV-1 virus can infect inner and outer foreskin polarized explants

artículo científico publicado en 2012

Cellular immune responses to HIV-1

artículo científico publicado el 1 de enero de 1998

Cellular immunity and target cell susceptibility in persons with repeated HIV-1 exposure

article

Cellular responses to the intradermal injection of recombinant human gamma-interferon in lepromatous leprosy patients

artículo científico publicado en 1987

Challenges and responses in human vaccine development.

artículo científico

Characterization of humoral and cellular immune responses elicited by a recombinant adenovirus serotype 26 HIV-1 Env vaccine in healthy adults (IPCAVD 001).

artículo científico publicado en 2012

Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual

scientific article published on 13 May 2020

Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers

artículo científico publicado en 1997

Coexpression of CCR5 and IL-2 in human genital but not blood T cells: implications for the ontogeny of the CCR5+ Th1 phenotype

artículo científico publicado en 1999

Combined effect of CCR5-Delta32 heterozygosity and the CCR5 promoter polymorphism -2459 A/G on CCR5 expression and resistance to human immunodeficiency virus type 1 transmission

artículo científico publicado en 2005

Comparative analysis of simian immunodeficiency virus gag-specific effector and memory CD8+ T cells induced by different adenovirus vectors

artículo científico publicado en 2012

Comparison of human immunodeficiency virus (HIV)-specific T-cell responses in HIV-1- and HIV-2-infected individuals in Senegal.

artículo científico publicado en 2004

Comparison of systemic and mucosal delivery of 2 canarypox virus vaccines expressing either HIV-1 genes or the gene for rabies virus G protein

artículo científico publicado en 2004

Comprehensive analysis of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-secreting CD8+ T cells in primary HIV-1 infection

artículo científico publicado en 2003

Comprehensive assessment of HIV target cells in the distal human gut suggests increasing HIV susceptibility toward the anus

artículo científico publicado en 2013

Comprehensive epitope analysis of cross-clade Gag-specific T-cell responses in individuals with early HIV-1 infection in the US epidemic

artículo científico publicado en 2006

Conserved HIV-1 epitopes continuously elicit subdominant cytotoxic T-lymphocyte responses

artículo científico publicado en 2009

Controlled Human Malaria Infection Leads to Long-Lasting Changes in Innate and Innate-like Lymphocyte Populations.

artículo científico publicado en 2017

Correction: Decreased Pre-existing Ad5 Capsid and Ad35 Neutralizing Antibodies Increase HIV-1 Infection Risk in the Step Trial Independent of Vaccination.

artículo científico publicado en 2012

Correction: Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization

artículo científico publicado en 2017

Correction: Genomewide Association Study for Determinants of HIV-1 Acquisition and Viral Set Point in HIV-1 Serodiscordant Couples with Quantified Virus Exposure.

artículo científico publicado en 2012

Correction: Musosal effects for tenofovir 1% gel.

artículo científico publicado en 2015

Correction: Whole genome sequencing of extreme phenotypes identifies variants in CD101 and UBE2V1 associated with increased risk of sexually acquired HIV-1

article

Correlation between interferon- gamma secretion and cytotoxicity, in virus-specific memory T cells

artículo científico publicado en 2004

Corrigendum: OMIP-056: Evaluation of Human Conventional T Cells, Donor-Unrestricted T Cells, and NK Cells Including Memory Phenotype by Intracellular Cytokine Staining

artículo científico publicado en 2020

Cryopreservation of Human Mucosal Leukocytes

artículo científico publicado en 2016

Cryopreservation of human mucosal tissues

artículo científico publicado en 2018

Cutaneous leishmaniasis. The defect in T cell influx in BALB/c mice

artículo científico publicado en 1987

Cutaneous response to recombinant interleukin 2 in human immunodeficiency virus 1-seropositive individuals

artículo científico publicado en 1990

Cytotoxic T cell and neutralizing antibody responses to human immunodeficiency virus type 1 envelope with a combination vaccine regimen. AIDS Vaccine Evaluation Group

artículo científico publicado en 1998

Cytotoxic and proliferative T cell responses in HIV-1-infected Macaca nemestrina

artículo científico publicado en 1995

Cytotoxic-T-Cell Responses, Viral Load, and Disease Progression in Early Human Immunodeficiency Virus Type 1 Infection ⬇️

artículo científico publicado el 30 de octubre de 1997

DNA Priming Increases Frequency of T-Cell Responses to a Vesicular Stomatitis Virus HIV Vaccine with Specific Enhancement of CD8+ T-Cell Responses by Interleukin-12 Plasmid DNA.

artículo científico publicado en 2017

DNA priming and gp120 boosting induces HIV-specific antibodies in a randomized clinical trial

artículo científico publicado en 2019

Daily Vaginal Swabs and Mobile Phone Sex Report for Assessing HIV Virion Exposure Prospectively Among a Cohort of Young Sexually Active Women in South Africa (HVTN 915)

scientific article published on 01 June 2019

Decreased Pre-existing Ad5 Capsid and Ad35 Neutralizing Antibodies Increase HIV-1 Infection Risk in the Step Trial Independent of Vaccination ⬇️

artículo científico publicado el 4 de abril de 2012

Defect in the tissue cellular immune response: experimental visceral leishmaniasis in euthymic C57BL/6 ep/ep mice

artículo científico publicado en 1990

Defining blood processing parameters for optimal detection of cryopreserved antigen-specific responses for HIV vaccine trials

artículo científico publicado en 2007

Demographic Processes Affect HIV-1 Evolution in Primary Infection before the Onset of Selective Processes ⬇️

artículo científico publicado el 18 de mayo de 2011

Demographic factors that influence the neutralizing antibody response in recipients of recombinant HIV-1 gp120 vaccines

artículo científico publicado en 2004

Dendritic cell-T-cell interactions support coreceptor-independent human immunodeficiency virus type 1 transmission in the human genital tract

artículo científico publicado en 1999

Detection of rectal antibodies to HIV-1 by a sensitive chemiluminescent western blot immunodetection method

artículo científico publicado en 1994

Determinants of antibody response after recombinant gp160 boosting in vaccinia-naive volunteers primed with gp160-recombinant vaccinia virus. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Clinical Trials Network

artículo científico publicado en 1994

Development of an automated analysis system for data from flow cytometric intracellular cytokine staining assays from clinical vaccine trials

artículo científico publicado en 2008

Differential regulatory T cell activity in HIV type 1-exposed seronegative individuals

artículo científico publicado en 2013

Differential specificity and immunogenicity of adenovirus type 5 neutralizing antibodies elicited by natural infection or immunization

artículo científico publicado en 2010

Dissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems Serology

artículo científico publicado en 2015

Distinct activation thresholds of human conventional and innate-like memory T cells

scientific article published on June 2016

Divergent patterns of progression to AIDS after infection from the same source: human immunodeficiency virus type 1 evolution and antiviral responses

artículo científico publicado en 1997

Durable HIV-1 antibody and T-cell responses elicited by an adjuvanted multi-protein recombinant vaccine in uninfected human volunteers

artículo científico publicado en 2006

Dynamics of Viral Evolution and CTL Responses in HIV-1 Infection ⬇️

artículo científico publicado el 20 de enero de 2011

Early and persistent human immunodeficiency virus type 1 (HIV-1)-specific T helper dysfunction in blood and lymph nodes following acute HIV-1 infection

artículo científico publicado en 1999

Early induction and maintenance of Env-specific T-helper cells following human immunodeficiency virus type 1 infection

artículo científico publicado en 2003

Effect of adjunct hydroxyurea on helper T cell immunity in HIV type 1-infected patients with virological suppression

artículo científico publicado en 2004

Effect of combination antiretroviral therapy on T-cell immunity in acute human immunodeficiency virus type 1 infection

artículo científico publicado en 2000

Effect of rAd5-Vector HIV-1 Preventive Vaccines on HIV-1 Acquisition: A Participant-Level Meta-Analysis of Randomized Trials

artículo científico publicado en 2015

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

artículo científico publicado en 2008

Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine

artículo científico publicado en 2013

Enhanced detection of human immunodeficiency virus type 1 (HIV-1) Nef-specific T cells recognizing multiple variants in early HIV-1 infection

artículo científico publicado en 2007

Enhanced immunity to human immunodeficiency virus (HIV) envelope elicited by a combined vaccine regimen consisting of priming with a vaccinia recombinant expressing HIV envelope and boosting with gp160 protein

artículo científico publicado en 1993

Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay ⬇️

artículo científico publicado el 16 de septiembre de 2012

Equivalence of ELISpot assays demonstrated between major HIV network laboratories

artículo científico publicado en 2010

Erratum: Corrigendum: Protective HIV-specific CD8+ T cells evade Treg cell suppression

scholarly article published in Nature Medicine

Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)

artículo científico publicado en 2018

Evaluation of cytotoxic T cell responses to candidate HIV-1 vaccines in HIV-1-uninfected individuals

scientific article published on 01 January 1994

Evaluation of human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T-lymphocyte responses utilizing B-lymphoblastoid cell lines transduced with the CD4 gene and infected with HIV-1.

artículo científico publicado en 1994

Evidence for the heterologous benefits of prior BCG vaccination on COVISHIELD™ vaccine-induced immune responses in SARS-CoV-2 seronegative young Indian adults

scientific article published in 2022

Evolution of CD8+ T cell immunity and viral escape following acute HIV-1 infection

artículo científico publicado en 2003

Evolution of human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitopes: fitness-balanced escape

artículo científico publicado en 2007

Ex vivo comparison of microbicide efficacies for preventing HIV-1 genomic integration in intraepithelial vaginal cells

artículo científico publicado en 2009

Experimental visceral leishmaniasis: role of endogenous IFN-gamma in host defense and tissue granulomatous response.

artículo científico publicado en 1989

FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial

artículo científico publicado en 2014

Fc Gamma Receptor Polymorphisms Modulated the Vaccine Effect on HIV-1 Risk in the HVTN 505 HIV Vaccine Trial

artículo científico publicado en 2019

Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization

artículo científico publicado en 2016

Functional properties and epitope characteristics of T-cells recognizing natural HIV-1 variants

artículo científico publicado en 2009

Generation of a cost-effective cell line for support of high-throughput isolation of primary human B cells and monoclonal neutralizing antibodies

scientific article published on 15 October 2020

Genetic association of the antiviral restriction factor TRIM5alpha with human immunodeficiency virus type 1 infection

artículo científico publicado en 2006

Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial ⬇️

artículo científico publicado el 27 de febrero de 2011

Genomewide association study for determinants of HIV-1 acquisition and viral set point in HIV-1 serodiscordant couples with quantified virus exposure

artículo científico publicado en 2011

HIV Vaccine Trials Network: activities and achievements of the first decade and beyond ⬇️

artículo científico publicado el 1 de marzo de 2012

HIV type 1 vaccine-induced cytotoxic T cell responses in phase I clinical trials: detection, characterization, and quantitation

artículo científico publicado en 1997

HIV type 1 vaccine-induced cytotoxic T cell responses: potential role in vaccine efficacy

artículo científico publicado en 1997

HIV vaccines induce CD8 <sup>+</sup> T cells with low antigen receptor sensitivity

artículo científico publicado en 2023

HIV vaccines: mosaic approach to virus diversity

artículo científico publicado en 2010

HIV-1 CTL-based vaccine immunogen selection: antigen diversity and cellular response features

artículo científico publicado en 2007

HIV-1 Gag co-opts a cellular complex containing DDX6, a helicase that facilitates capsid assembly

artículo científico publicado en 2012

HIV-1 VACCINES. Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodies

artículo científico publicado en 2015

HIV-1 Vaccine Sequences Impact V1V2 Antibody Responses: A Comparison of Two Poxvirus Prime gp120 Boost Vaccine Regimens

artículo científico publicado en 2020

HIV-1 induces cytotoxic T lymphocytes in the cervix of infected women

artículo científico publicado en 1997

HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders

artículo científico publicado en 2015

HIV-1 integration landscape during latent and active infection

artículo científico publicado en 2015

HIV-1 single-stranded RNA induces CXCL13 secretion in human monocytes via TLR7 activation and plasmacytoid dendritic cell-derived type I IFN.

artículo científico publicado en 2015

HIV-1 specific IgA detected in vaginal secretions of HIV uninfected women participating in a microbicide trial in Southern Africa are primarily directed toward gp120 and gp140 specificities

artículo científico publicado en 2014

HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1.

artículo científico publicado en 2016

HIV-1 vaccination administered intramuscularly can induce both systemic and mucosal T cell immunity in HIV-1-uninfected individuals

artículo científico publicado en 2003

HIV-1 vaccine-induced T-cell responses cluster in epitope hotspots that differ from those induced in natural infection with HIV-1.

artículo científico publicado en 2013

HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis

artículo científico publicado en 2008

HIV-1MN recombinant glycoprotein 160 vaccine-induced cellular and humoral immunity boosted by HIV-1MN recombinant glycoprotein 120 vaccine. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group.

artículo científico publicado en 1999

HIV-DNA priming alters T cell responses to HIV-adenovirus vaccine even when responses to DNA are undetectable

artículo científico publicado en 2011

HIV-Specific CD8+ T-cell Expansion Potential, but Not Cytotoxic Capacity, Is Associated with Reduced Set Point Viral Loads in Ad5/HIV Vaccinees.

artículo científico publicado en 2014

HIV-infected macrophages as efficient stimulator cells for detection of cytotoxic T cell responses to HIV in seronegative and seropositive vaccine recipients

scientific article published on 01 May 1994

HIV-specific humoral responses benefit from stronger prime in phase Ib clinical trial

artículo científico publicado en 2014

HLA class II genes modulate vaccine-induced antibody responses to affect HIV-1 acquisition

artículo científico publicado en 2015

Hepatitis c virus-specific cytolytic t cell responses after antiviral therapy ⬇️

artículo científico publicado el 1 de septiembre de 2003

Herpes Simplex Virus Suppressive Therapy in Herpes Simplex Virus-2/Human Immunodeficiency Virus-1 Coinfected Women Is Associated With Reduced Systemic CXCL10 But Not Genital Cytokines

artículo científico publicado en 2016

Higher T-Cell Responses Induced by DNA/rAd5 HIV-1 Preventive Vaccine Are Associated With Lower HIV-1 Infection Risk in an Efficacy Trial

artículo científico publicado en 2017

High‐Dose Recombinant Canarypox Vaccine Expressing HIV‐1 Protein, in Seronegative Human Subjects

article

Host genetic determinants of T cell responses to the MRKAd5 HIV-1 gag/pol/nef vaccine in the step trial

artículo científico publicado en 2011

Host genetic polymorphisms associated with innate immune factors and HIV-1 ⬇️

artículo científico publicado el 1 de septiembre de 2011

Human CD1a Deficiency Is Common and Genetically Regulated ⬇️

artículo científico publicado el 15 de julio de 2013

Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine

artículo científico publicado en 2011

Human immunodeficiency virus type 1 infection despite prior immunization with a recombinant envelope vaccine regimen

scientific article published on April 1996

Human immunodeficiency virus type 1 mediates global disruption of innate antiviral signaling and immune defenses within infected cells

artículo científico publicado en 2009

Human immunodeficiency virus-specific and CD3-redirected cytotoxic T lymphocyte activity in the human female reproductive tract: lack of correlation between mucosa and peripheral blood

artículo científico publicado en 2001

Identification and visualization of multidimensional antigen-specific T-cell populations in polychromatic cytometry data.

artículo científico publicado en 2015

Identification of effective subdominant anti-HIV-1 CD8+ T cells within entire post-infection and post-vaccination immune responses

artículo científico publicado en 2015

Immune Responses to HIV Vaccines and Potential Impact on Control of Acute HIV‐1 Infection ⬇️

artículo científico publicado el 15 de octubre de 2010

Immune correlates of the Thai RV144 HIV vaccine regimen in South Africa

scientific article published on 01 September 2019

Immune defence against HIV-1 infection in HIV-1-exposed seronegative persons

article

Immune responses elicited by recombinant vaccinia-human immunodeficiency virus (HIV) envelope and HIV envelope protein: analysis of the durability of responses and effect of repeated boosting

artículo científico publicado en 1994

Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation Group

artículo científico publicado en 1998

Immune-correlates analysis of an HIV-1 vaccine efficacy trial

artículo científico publicado en 2012

Immune-correlates analysis of an HIV-1 vaccine efficacy trial reveals an association of nonspecific interferon-γ secretion with increased HIV-1 infection risk: a cohort-based modeling study

artículo científico publicado en 2014

Immunization with cocktail of HIV-derived peptides in montanide ISA-51 is immunogenic, but causes sterile abscesses and unacceptable reactogenicity

artículo científico publicado en 2010

Immunization with envelope MN rgp120 vaccine in human immunodeficiency virus-infected pregnant women

artículo científico publicado en 1999

Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Ev

artículo científico publicado en 1996

Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adults

artículo científico publicado en 2017

Impaired viral entry cannot explain reduced CD4+ T cell susceptibility to HIV type 1 in certain highly exposed individuals

artículo científico publicado en 2008

In Situ Staining and Laser Capture Microdissection of Lymph Node Residing SIV Gag-Specific CD8+ T cells--A Tool to Interrogate a Functional Immune Response Ex Vivo

artículo científico publicado en 2016

In men at risk of HIV infection, IgM, IgG1, IgG3, and IgA reach the human foreskin epidermis

artículo científico publicado en 2015

In situ detection of Gag-specific CD8+ cells in the GI tract of SIV infected Rhesus macaques

artículo científico publicado en 2010

Incomplete immune reconstitution after initiation of highly active antiretroviral therapy in human immunodeficiency virus-infected patients with severe CD4+ cell depletion

artículo científico publicado en 2003

Increased sequence coverage through combined targeting of variant and conserved epitopes correlates with control of HIV replication

artículo científico publicado en 2013

Induction of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses in HIV vaccine trial participants who subsequently acquire HIV-1 infection

artículo científico publicado en 2006

Induction of immunity to human immunodeficiency virus type-1 by vaccination

artículo científico publicado en 2010

Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1.

artículo científico publicado en 2007

Innate immune signaling induces high levels of TC-specific deaminase activity in primary monocyte-derived cells through expression of APOBEC3A isoforms

artículo científico publicado en 2010

Innate immune signatures to a partially-efficacious HIV vaccine predict correlates of HIV-1 infection risk

artículo científico publicado en 2021

Innovative approaches to track lymph node germinal center responses to evaluate development of broadly neutralizing antibodies in human HIV vaccine trials

article

Integrated analysis of multimodal single-cell data

artículo científico publicado en 2021

Integrated systems approach defines the antiviral pathways conferring protection by the RV144 HIV vaccine

article

Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine

artículo científico publicado en 2021

Interleukin-2 reconstitutes defective human immunodeficiency virus (HIV), and cytomegalovirus (CMV) specific CD8+ T cell proliferation in HIV infection

artículo científico publicado en 2006

Is an HIV vaccine possible?

artículo científico publicado en 2012

Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+ subjects

artículo científico publicado en 2021

Landscapes of binding antibody and T-cell responses to pox-protein HIV vaccines in Thais and South Africans

scientific article published on 30 January 2020

Latent HIV-1 infection in enriched populations of blood monocytes and T cells from seropositive patients

artículo científico publicado en 1991

Leveraging lessons learned from the COVID-19 pandemic for HIV

scientific article published in 2022

Long-term effect of depot medroxyprogesterone acetate on vaginal microbiota, epithelial thickness and HIV target cells

artículo científico publicado en 2014

Longitudinal analysis of quantitative virologic measures in human immunodeficiency virus-infected subjects with > or = 400 CD4 lymphocytes: implications for applying measurements to individual patients. National Institute of Allergy and Infectious D

artículo científico publicado en 1997

MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data

artículo científico publicado en 2015

MRKAd5 HIV-1 Gag/Pol/Nef vaccine-induced T-cell responses inadequately predict distance of breakthrough HIV-1 sequences to the vaccine or viral load

artículo científico publicado en 2012

Macaques infected with a CCR5-tropic simian/human immunodeficiency virus (SHIV) develop broadly reactive anti-HIV neutralizing antibodies

artículo científico publicado en 2007

Mapping HIV-1 vaccine induced T-cell responses: bias towards less-conserved regions and potential impact on vaccine efficacy in the Step study

artículo científico publicado en 2011

Measuring inhibition of HIV replication by ex vivo CD8⁺ T cells

artículo científico publicado en 2013

Mechanisms of endogenous HIV-1 reactivation by endocervical epithelial cells

artículo científico publicado en 2020

Merck Ad5/HIV induces broad innate immune activation that predicts CD8⁺ T-cell responses but is attenuated by preexisting Ad5 immunity

artículo científico publicado en 2012

Modification of the Association Between T-Cell Immune Responses and Human Immunodeficiency Virus Type 1 Infection Risk by Vaccine-Induced Antibody Responses in the HVTN 505 Trial

artículo científico publicado en 2018

Modulation of immunologic responses to HIV-1MN recombinant gp160 vaccine by dose and schedule of administration. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group

scientific article published on 01 March 1998

Mononuclear phagocytes of blood and bone marrow: comparative roles as viral reservoirs in human immunodeficiency virus type 1 infections

artículo científico publicado en 1989

Most CD4+ T cells from human immunodeficiency virus-1 infected patients can undergo prolonged clonal expansion

artículo científico publicado en 1989

Most DC-SIGNR transcripts at mucosal HIV transmission sites are alternatively spliced isoforms

artículo científico publicado en 2005

Most highly exposed seronegative men lack HIV-1-specific, IFN-gamma-secreting T cells

artículo científico publicado en 2003

Moving to human immunodeficiency virus type 1 vaccine efficacy trials: defining T cell responses as potential correlates of immunity

artículo científico publicado en 2003

Mucosal effects of tenofovir 1% gel

artículo científico publicado en 2015

Mucosal effects of tenofovir 1% gel

Neutralization Takes Precedence Over IgG or IgA Isotype-related Functions in Mucosal HIV-1 Antibody-mediated Protection

artículo científico publicado en 2016

Neutralization of a clade B primary isolate by sera from human immunodeficiency virus-uninfected recipients of candidate AIDS vaccines

artículo científico publicado en 1997

Novel cytotoxic T-lymphocyte escape mutation by a three-amino-acid insertion in the human immunodeficiency virus type 1 p6Pol and p6Gag late domain associated with drug resistance

artículo científico publicado en 2007

OA06-06 LB. Evidence of vaccine-induced changes in breakthrough HIV-1 strains from the Step trial

article by M Rolland et al published 22 October 2009 in Retrovirology

OMIP-024: pan-leukocyte immunophenotypic characterization of PBMC subsets in human samples

artículo científico publicado en 2014

OMIP-025: evaluation of human T- and NK-cell responses including memory and follicular helper phenotype by intracellular cytokine staining

artículo científico publicado en 2014

OMIP-056: Evaluation of Human Conventional T Cells, Donor-Unrestricted T Cells, and NK Cells Including Memory Phenotype by Intracellular Cytokine Staining

scientific article published on 28 March 2019

OMIP-064: A 27-Color Flow Cytometry Panel to Detect and Characterize Human NK Cells and Other Innate Lymphoid Cell Subsets, MAIT Cells, and γδ T Cells

artículo científico publicado en 2020

OMIP‐014: Validated multifunctional characterization of antigen‐specific human T cells by intracellular cytokine staining ⬇️

artículo científico publicado el 18 de octubre de 2012

One shot forward for HIV prevention

artículo científico publicado en 2014

Ontogeny and specificities of mucosal and blood human immunodeficiency virus type 1-specific CD8(+) cytotoxic T lymphocytes

artículo científico publicado en 2003

Optimization and qualification of a memory B-cell ELISpot for the detection of vaccine-induced memory responses in HIV vaccine trials ⬇️

artículo científico publicado el 23 de mayo de 2013

Optimization and qualification of a multiplex bead array to assess cytokine and chemokine production by vaccine-specific cells

artículo científico publicado en 2012

Optimization and validation of an 8-color intracellular cytokine staining (ICS) assay to quantify antigen-specific T cells induced by vaccination

artículo científico publicado en 2007

Optimization of a whole blood phenotyping assay for enumeration of peripheral blood leukocyte populations in multicenter clinical trials

artículo científico publicado en 2014

Optimizing viable leukocyte sampling from the female genital tract for clinical trials: an international multi-site study

artículo científico publicado en 2014

Origin and differentiation of human memory CD8 T cells after vaccination

artículo científico publicado en 2017

P08-06 LB. A genome-wide association study of host genetic determinants of T cell responses to the MRKAd5 HIV-1 gag/pol/nef vaccine in the STEP trial.

artículo científico publicado en 2009

P14-11. Educating community medical providers about HIV vaccine induced seropositivity

article

P17-22. Impact of rare adenovirus seroprevalence on HIV-1 acquisition in the Step study

article

P17-25. A model for coverage of T-cell HIV vaccines: where are we and where do we need to be?

article

P19-48. Induction of Ad5 neutralizing antibodies in placebo recipients during the Step Trial is not associated with risk of HIV infection

artículo científico publicado en 2009

Peptide selection for human immunodeficiency virus type 1 CTL-based vaccine evaluation

artículo científico publicado en 2006

Persistence of Extraordinarily Low Levels of Genetically Homogeneous Human Immunodeficiency Virus Type 1 in Exposed Seronegative Individuals ⬇️

artículo científico publicado el 1 de junio de 2003

Phase 1 HIV vaccine trial to evaluate the safety and immunogenicity of HIV subtype C DNA and MF59-adjuvanted subtype C Env protein

scientific article published on 04 January 2020

Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120: negative results fail to trigger a phase 3 correlates trial

artículo científico publicado en 2007

Phase 2a safety and immunogenicity testing of DNA and recombinant modified vaccinia ankara virus vaccines expressing virus-like particles

artículo científico publicado en 2012

Phase I/II randomized trial of safety and immunogenicity of LIPO-5 alone, ALVAC-HIV (vCP1452) alone, and ALVAC-HIV (vCP1452) prime/LIPO-5 boost in healthy, HIV-1-uninfected adult participants

artículo científico publicado en 2014

Plasma cytokine levels and risk of HIV type 1 (HIV-1) transmission and acquisition: a nested case-control study among HIV-1-serodiscordant couples

artículo científico publicado en 2014

Polyinosinic-Polycytidylic Acid Is the Most Effective TLR Adjuvant for SIV Gag Protein–Induced T Cell Responses In Nonhuman Primates ⬇️

artículo científico publicado el 15 de marzo de 2013

Polymorphisms in toll-like receptor 4 and toll-like receptor 9 influence viral load in a seroincident cohort of HIV-1-infected individuals

artículo científico publicado en 2009

Polytopic fractional delivery of an HIV vaccine alters cellular responses and results in increased epitope breadth in a phase 1 randomized trial

artículo científico publicado en 2024

Pooled-Peptide Epitope Mapping Strategies Are Efficient and Highly Sensitive: An Evaluation of Methods for Identifying Human T Cell Epitope Specificities in Large-Scale HIV Vaccine Efficacy Trials

artículo científico publicado en 2016

Post-step modifications for research on HIV vaccines

artículo científico publicado en 2009

Pre-existing adenovirus immunity modifies a complex mixed Th1 and Th2 cytokine response to an Ad5/HIV-1 vaccine candidate in humans

artículo científico publicado en 2011

Predictors of durable immune responses six months after the last vaccination in preventive HIV vaccine trials

artículo científico

Preinfection human immunodeficiency virus (HIV)-specific cytotoxic T lymphocytes failed to prevent HIV type 1 infection from strains genetically unrelated to viruses in long-term exposed partners

artículo científico publicado en 2009

Preservation of T Cell Proliferation Restricted by Protective HLA Alleles Is Critical for Immune Control of HIV-1 Infection

article

Preventing discrimination against volunteers in prophylactic HIV vaccine trials: lessons from a phase II trial

artículo científico publicado en 1998

Priming CD8+ T cells with dendritic cells matured using TLR4 and TLR7/8 ligands together enhances generation of CD8+ T cells retaining CD28.

artículo científico publicado en 2011

Profiles of human serum antibody responses elicited by three leading HIV vaccines focusing on the induction of Env-specific antibodies

artículo científico publicado en 2010

Profiling immunity to HIV vaccines with systems biology ⬇️

artículo científico publicado el 1 de enero de 2012

Progress in HIV-1 vaccine development

article

Progress in the development of a preventive HIV-1 vaccine

artículo científico publicado en 2002

Protection against human immunodeficiency virus type 1 infection in persons with repeated exposure: evidence for T cell immunity in the absence of inherited CCR5 coreceptor defects

artículo científico publicado en 1999

Protective HIV-specific CD8+ T cells evade Treg cell suppression ⬇️

artículo científico publicado el 17 de julio de 2011

QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immmunization in humans

article

Quantifying ongoing HIV-1 exposure in HIV-1-serodiscordant couples to identify individuals with potential host resistance to HIV-1

artículo científico publicado en 2012

RTS,S/AS01E Malaria Vaccine Induces Memory and Polyfunctional T Cell Responses in a Pediatric African Phase III Trial

artículo científico publicado en 2017

Rank-based two-sample tests for paired data with missing values

artículo científico publicado en 2017

Rapid Boosting of HIV-1 Neutralizing Antibody Responses in Humans Following a Prolonged Immunologic Rest Period

scientific article published on 01 May 2019

Rapid Collection of Human Rectal Secretions Using OriCol Devices Is Suitable for Measurement of Mucosal Ig without Blood Contamination

scientific article published on 14 September 2020

Rapid development of cross-clade neutralizing antibody responses after clade B gp120/gp140 protein priming and clade c gp140 protein boosting

artículo científico publicado en 2012

Recombinant HIV-1 glycoprotein 120 induces distinct types of delayed hypersensitivity in persons with or without pre-existing immunologic memory

artículo científico publicado en 2001

Recombinant HIV-1 vaccine candidates based on replication-defective flavivirus vector

artículo científico publicado en 2019

Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study

artículo científico publicado en 2014

Regulatory T-Cell Activity But Not Conventional HIV-Specific T-Cell Responses Are Associated With Protection From HIV-1 Infection

artículo científico publicado en 2015

Repeat-region polymorphisms in the gene for the dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin-related molecule: effects on HIV-1 susceptibility

artículo científico publicado en 2006

Reply

Response to Guo et al.'s Letter to the Editor

scientific article published on 01 April 2019

Robust antibody and cellular responses induced by DNA-only vaccination for HIV

artículo científico publicado en 2020

Role for HLA class II molecules in HIV-1 suppression and cellular immunity following antiretroviral treatment

artículo científico publicado en 2001

Role of human immunodeficiency virus (HIV)-specific T-cell immunity in control of dual HIV-1 and HIV-2 infection

artículo científico publicado en 2007

Safety Profile of Phase I and II Preventive HIV Type 1 Envelope Vaccination: Experience of the NIAID AIDS Vaccine Evaluation Group ⬇️

artículo científico publicado el 20 de septiembre de 1997

Safety and Immunogenicity of Novel Adenovirus Type 26- and Modified Vaccinia Ankara-Vectored Ebola Vaccines: A Randomized Clinical Trial

artículo científico publicado en 2016

Safety and Immunogenicity of a Recombinant Adenovirus Serotype 35-Vectored HIV-1 Vaccine in Adenovirus Serotype 5 Seronegative and Seropositive Individuals

artículo científico publicado en 2015

Safety and Immunogenicity of an HIV Adenoviral Vector Boost after DNA Plasmid Vaccine Prime by Route of Administration: A Randomized Clinical Trial ⬇️

artículo científico publicado el 12 de septiembre de 2011

Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study

artículo científico publicado en 2011

Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines

artículo científico publicado en 2020

Safety and immunogenicity of Env 2-3, a human immunodeficiency virus type 1 candidate vaccine, in combination with a novel adjuvant, MTP-PE/MF59. NIAID AIDS Vaccine Evaluation Group

artículo científico publicado en 1996

Safety and immunogenicity of a CTL multiepitope peptide vaccine for HIV with or without GM-CSF in a phase I trial

artículo científico publicado en 2008

Safety and immunogenicity of a candidate HIV-1 vaccine in healthy adults: recombinant glycoprotein (rgp) 120. A randomized, double-blind trial. NIAID AIDS Vaccine Evaluation Group

artículo científico publicado en 1996

Safety and immunogenicity of a fully glycosylated recombinant gp160 human immunodeficiency virus type 1 vaccine in subjects at low risk of infection. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group Network.

artículo científico publicado en 1993

Safety and immunogenicity of a high-titered canarypox vaccine in combination with rgp120 in a diverse population of HIV-1-uninfected adults: AIDS Vaccine Evaluation Group Protocol 022A.

artículo científico publicado en 2002

Safety and immunogenicity of a multivalent HIV vaccine comprising envelope protein with either DNA or NYVAC vectors (HVTN 096): a phase 1b, double-blind, placebo-controlled trial

artículo científico publicado en 2019

Safety and immunogenicity of a replication-defective adenovirus type 5 HIV vaccine in Ad5-seronegative persons: a randomized clinical trial (HVTN 054)

artículo científico publicado en 2010

Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1/2a study

scientific article published on 01 October 2020

Safety and tolerability of HIV-1 multiantigen pDNA vaccine given with IL-12 plasmid DNA via electroporation, boosted with a recombinant vesicular stomatitis virus HIV Gag vaccine in healthy volunteers in a randomized, controlled clinical trial

artículo científico publicado en 2018

Safety profile of HIV vaccination: first 1000 volunteers of AIDS vaccine evaluation group. NIAID AIDS Vaccine Clinical Trials Network

artículo científico publicado en 1994

Selection of HIV vaccine candidates for concurrent testing in an efficacy trial

artículo científico publicado en 2016

Selection of potent immunological adjuvants for vaccine construction

artículo científico publicado en 1995

Selection on the human immunodeficiency virus type 1 proteome following primary infection

artículo científico publicado en 2006

Sequence and vector shapes vaccine induced antibody effector functions in HIV vaccine trials

artículo científico publicado en 2021

Serological immunity to adenovirus serotype 5 is not associated with risk of HIV infection: a case–control study ⬇️

artículo científico publicado el 14 de enero de 2011

Setting the stage: host invasion by HIV.

artículo científico publicado en 2008

Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120.

artículo científico publicado en 2017

Specific activation strategies for amplification of low CTL signals

artículo científico publicado el 1 de agosto de 1992

Specificity and 6-month durability of immune responses induced by DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles

artículo científico publicado en 2014

Standing guard at the mucosa

artículo científico publicado en 2011

Statistical considerations for the design and analysis of the ELISpot assay in HIV-1 vaccine trials

artículo científico publicado en 2004

Structural Characterization of Immune Responses to HPV Infection and HPV Vaccination

scholarly article

Studies of high doses of a human immunodeficiency virus type 1 recombinant glycoprotein 160 candidate vaccine in HIV type 1-seronegative humans. The AIDS Vaccine Clinical Trials Network.

artículo científico publicado en 1994

Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial.

artículo científico publicado en 2018

T Cell Responses against Mycobacterial Lipids and Proteins Are Poorly Correlated in South African Adolescents

artículo científico publicado en 2015

T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant

artículo científico publicado en 2019

T cell responses generated by HIV vaccines in clinical trials

artículo científico publicado en 2008

T-cell based sieve analysis ties HLA A*02 to vaccine efficacy and IgA-C1 immune correlate in RV144 Thai trial

artículo científico publicado en 2012

Targeting an alternate Wilms’ tumor antigen 1 peptide bypasses immunoproteasome dependency

artículo científico publicado en 2022

Th2-Biased Transcriptional Profile Predicts HIV Envelope-Specific Polyfunctional CD4<sup>+</sup> T Cells That Correlated with Reduced Risk of Infection in RV144 Trial

artículo científico publicado en 2022

The dynamics of granuloma formation in experimental visceral leishmaniasis

artículo científico publicado en 1988

The inner foreskin of healthy males at risk of HIV infection harbors epithelial CD4+ CCR5+ cells and has features of an inflamed epidermal barrier

artículo científico publicado en 2014

The local cellular immune response in experimental leishmaniasis

scientific article published on 01 September 1987

The major genetic determinants of HIV-1 control affect HLA class I peptide presentation

artículo científico publicado en 2010

The pharmacokinetics and serum and urine bactericidal activity of ciprofloxacin

artículo científico publicado en 1985

The pharmacology of orally administered ciprofloxacin

scientific article published on 01 January 1985

Timing of plasmid cytokine (IL-2/Ig) administration affects HIV-1 vaccine immunogenicity in HIV-seronegative subjects

artículo científico publicado en 2011

Toll-like receptor polymorphism associations with HIV-1 outcomes among sub-Saharan Africans

artículo científico publicado en 2013

Towards prediction of degenerate CTL epitope recognition

artículo científico publicado en 2008

Transcriptional correlates of malaria in RTS,S/AS01-vaccinated African children: a matched case-control study

scientific article published on 21 January 2022

Transient Peripheral Immune Activation follows Elective Sigmoidoscopy or Circumcision in a Cohort Study of MSM at Risk of HIV Infection

artículo científico publicado en 2016

Treatment with Commonly Used Antiretroviral Drugs Induces a Type I/III Interferon Signature in the Gut in the Absence of HIV Infection

scientific article published on 22 September 2020

Trivalent adenovirus type 5 HIV recombinant vaccine primes for modest cytotoxic capacity that is greatest in humans with protective HLA class I alleles

artículo científico publicado en 2011

Two double-blinded, randomized, comparative trials of 4 human immunodeficiency virus type 1 (HIV-1) envelope vaccines in HIV-1-infected individuals across a spectrum of disease severity: AIDS Clinical Trials Groups 209 and 214.

artículo científico publicado en 2000

Two new monoclonal antibodies for biochemical and flow cytometric analyses of human interferon regulatory factor-3 activation, turnover, and depletion

artículo científico publicado en 2012

Use of adenovirus type-5 vectored vaccines: a cautionary tale

artículo científico publicado en 2020

Use of placebos in Phase 1 preventive HIV vaccine clinical trials

artículo científico publicado en 2014

Vaccination With Heterologous HIV-1 Envelope Sequences and Heterologous Adenovirus Vectors Increases T-Cell Responses to Conserved Regions: HVTN 083

artículo científico publicado en 2015

Vaccination establishes clonal relatives of germinal center T cells in the blood of humans.

artículo científico publicado en 2017

Vaccination induces HIV broadly neutralizing antibody precursors in humans ⬇️

artículo científico publicado en 2022

Vaccination with MVA/HIV induces differential recruitment of monocyte subsets into the circulation and monocyte-specific transcriptional programs

article

Vaccine-Induced Antibodies Mediate Higher Antibody-Dependent Cellular Cytotoxicity After Interleukin-15 Pretreatment of Natural Killer Effector Cells

scientific article published on 27 November 2019

Vaccine-Induced Linear Epitope-Specific Antibodies to Simian Immunodeficiency Virus SIVmac239 Envelope Are Distinct from Those Induced to the Human Immunodeficiency Virus Type 1 Envelope in Nonhuman Primates

artículo científico publicado en 2015

Vaccine-induced HIV-specific CD8+ T cells utilize preferential HLA alleles and target-specific regions of HIV-1.

artículo científico publicado en 2011

Vaccine-induced gag-specific T cells are associated with reduced viremia after HIV-1 infection

artículo científico publicado en 2013

Vaginal langerhans cells nonproductively transporting HIV-1 mediate infection of T cells

artículo científico publicado en 2011

Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) response

artículo científico publicado en 2009

Variants in host viral replication cycle genes are associated with heterosexual HIV-1 acquisition in Africans

artículo científico publicado en 2014

Virus-specific CD8+ T-cell responses better define HIV disease progression than HLA genotype

artículo científico publicado en 2010

Vpu mediates depletion of interferon regulatory factor 3 during HIV infection by a lysosome-dependent mechanism

artículo científico publicado en 2012

Vpu-deficient HIV strains stimulate innate immune signaling responses in target cells

artículo científico publicado en 2012

Whole genome sequencing of extreme phenotypes identifies variants in CD101 and UBE2V1 associated with increased risk of sexually acquired HIV-1.

artículo científico publicado en 2017

mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection

artículo científico publicado en 2021

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda